Tanglewood Legacy Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$92K Hold
100
0.03% 133
2025
Q4
$107K Hold
100
0.04% 127
2025
Q3
$76.3K Hold
100
0.03% 145
2025
Q2
$78K Hold
100
0.03% 146
2025
Q1
$82.6K Sell
100
-4
-4% -$3.33K 0.04% 139
2024
Q4
$80.3K Hold
104
0.03% 140
2024
Q3
$92.1K Hold
104
0.04% 129
2024
Q2
$94.2K Hold
104
0.04% 121
2024
Q1
$80.9K Buy
104
+4
+4% +$2.85K 0.04% 135
2023
Q4
$58.3K Hold
100
0.03% 141
2023
Q3
$53.7K Hold
100
0.03% 149
2023
Q2
$46.9K Hold
100
0.03% 168
2023
Q1
$34.3K Hold
100
0.02% 176
2022
Q4
$36.6K Buy
+100
New +$35.5K 0.03% 148

Other funds holding LLY

Tanglewood Legacy Advisors's LLY Position: Q1 2026 in Review

Tanglewood Legacy Advisors held its Eli Lilly (LLY) position steady in Q1 2026 at 100 shares worth $92K. The position accounts for 0.03% of the portfolio, ranked #133.

Tanglewood Legacy Advisors first reported a position in LLY in Q4 2022 and has held it in 14 quarters since. The position peaked at $107K in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Tanglewood Legacy Advisors held 100 shares of Eli Lilly worth $92K as of Q1 2026.
  • Tanglewood Legacy Advisors left its Eli Lilly share count unchanged in Q1 2026.
  • Eli Lilly made up 0.03% of Tanglewood Legacy Advisors's portfolio in Q1 2026, its #133 holding.
  • Tanglewood Legacy Advisors first reported a position in Eli Lilly in Q4 2022 and has held it in 14 quarters since.
  • Tanglewood Legacy Advisors's Eli Lilly position peaked at $107K in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Tanglewood Legacy Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.